Transaction DateRecipientSharesTypePriceValue
6th July 2020Michael L. Meyers3,500Grant/award etc.$0.00
23rd June 2020Briggs Morrison4,800Open or private purchase$20.00$96,000.00
24th March 2020Briggs Morrison2,500Open or private purchase$38.18$95,450.00
12th February 2020Michael A Metzger15,000Grant/award etc.$0.00
4th February 2020Briggs Morrison12,500Open or private purchase$8.00$100,000.00
31st January 2020Richard P Shea1,505Other acquisition or disposition$7.97$11,994.85
13th December 2019Richard P Shea7,500Open or private purchase$2.74$20,550.00
10th October 2019Briggs Morrison11,000Open or private purchase$5.40$59,400.00
31st July 2019Richard P Shea1,401Other acquisition or disposition$4.89$6,850.89
13th May 2019Briggs Morrison7,200Open or private purchase$7.29$52,516.80
Syndax Pharmaceuticals
Syndax Pharmaceuticals logo

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005.

Ticker: SNDX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1395937
Employees: 35
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals